© Copyright 2026 American Medical Association. All rights reserved.
Immunotherapy administration with electroporation, intramuscular (CPT® Code 0732T) is a specialized technique designed to enhance the delivery of DNA-based vaccine treatments. This method utilizes a handheld needle array device that not only injects the therapeutic agent but also employs electroporation to facilitate improved cellular uptake and a more robust immunoresponse. This technique is particularly relevant in the treatment of diseases such as cancer and HIV, where effective immune activation is crucial. The process begins with the preparation of the needle array device, which is loaded with a drug cartridge and adjusted to the appropriate needle depth for optimal delivery. The device is engineered to apply electrical pulses that temporarily increase the permeability of cell membranes, thereby enhancing the uptake of the vaccine and promoting a greater antigen production response. The careful calibration of electroporation parameters—such as pulse strength, duration, and intervals—is essential to maximize cellular transfer while minimizing potential tissue damage. During the procedure, the physician ensures the patient is positioned correctly and stabilizes the treatment site to prevent movement. Once the drug is injected and the electropulses are administered, the single-use needle array is disposed of properly, and the handset is returned to its docking station, ensuring adherence to safety and hygiene protocols.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.